Related Experiment Video
Updated: Apr 15, 2026
07:58
Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
Published on: May 30, 2017
11.6K
Cholera toxin B: one subunit with many pharmaceutical applications.
Keegan J Baldauf1, Joshua M Royal2, Krystal Teasley Hamorsky3,4
1Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA. keegan.baldauf@louisville.edu.
Toxins
|March 25, 2015
Summary
Cholera toxin B subunit (CTB) shows promise beyond vaccines. It acts as an immunomodulatory and anti-inflammatory agent, offering new therapeutic possibilities for various conditions.
Area of Science:
- Immunology
- Microbiology
- Biotechnology
Background:
- Cholera, caused by Vibrio cholerae, is a severe diarrheal disease linked to poor sanitation.
- Cholera toxin (CT) is the main virulence factor, composed of A and B subunits (CTA and CTB).
- CTB is a non-toxic, homopentameric protein that binds to GM1 ganglioside on host cells.
Purpose of the Study:
- To review the immunomodulatory and anti-inflammatory potential of CTB.
- To summarize available recombinant expression systems for CTB bioproduction.
Main Methods:
- Review of existing literature on CTB's biological activities.
- Analysis of studies investigating CTB's effects on immune responses.
- Survey of recombinant protein expression platforms for CTB.
Main Results:
- Recombinant CTB is a component of an effective oral cholera vaccine, inducing protective humoral immunity.
- Emerging evidence indicates CTB administration triggers in vivo anti-inflammatory mechanisms.
- Various recombinant expression systems are suitable for producing CTB.
Conclusions:
- CTB exhibits significant potential as an immunomodulatory and anti-inflammatory agent.
- Further research into CTB's therapeutic applications beyond cholera prevention is warranted.
- Efficient bioproduction methods support the development of CTB-based therapeutics.
More Related Videos
Related Concept Videos
01:25Cholera
92
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
92
01:12Bacterial Toxins
95
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
95
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.4K
01:18Bacterial Gastroenteritis
63
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
63
01:28Diphtheria
141
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
141
01:09GPCRs Regulate Adenylyl Cylase Activity
8.4K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.4K